Literature DB >> 26022193

Comparability of Icare Pro Rebound Tonometer with Goldmann Applanation and Noncontact Tonometer in a Wide Range of Intraocular Pressure and Central Corneal Thickness.

Nevbahar Tamçelik1, Eray Atalay, Erdogan Cicik, Ahmet Özkök.   

Abstract

PURPOSE: To evaluate the agreement between the reading values of the Goldmann applanation tonometer (GAT), Icare Pro rebound tonometer (IRT) and noncontact tonometer (NCT) in glaucoma patients.
METHODS: This cross-sectional study comprised 292 eyes of 292 patients selected from a glaucoma outpatient clinic. The intraocular pressure (IOP) was measured sequentially, at a 10-min interval each, in the following order: NCT, IRT and GAT. The central corneal thickness (CCT) was measured using Pentacam HR before the IOP measurements.
RESULTS: The mean IOPs measured by the GAT, NCT and IRT were 20.17 ± 6.73 mm Hg (range: 4-48), 19.77 ± 6.88 mm Hg (range: 3-46) and 19.30 ± 5.15 mm Hg (range: 7.30-44.5), respectively. The correlation coefficients of the GAT and IRT, NCT and IRT, and GAT and NCT measurements were r(2) = 0.673, r(2) = 0.663 and r(2) = 0.938 (all p < 0.001), respectively. The IRT tends to overestimate in the low GAT-measured IOPs, whereas it underestimates in high GAT-measured IOPs. The measurements of all 3 devices were also correlated with the CCT at a statistically significant level (GAT: r(2) = 0.063, NCT: r(2) = 0.063, IRT: r(2) = 0.058).
CONCLUSION: The agreement between the IRT and GAT measurements is higher in the IOP range of 9-22 mm Hg, whereas significant discrepancies occur as the IOP deviates from normal values. The variability of the IRT and GAT measurements over a wide range of CCT is minimal.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26022193     DOI: 10.1159/000381781

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  8 in total

1.  Agreement among Goldmann applanation tonometer, iCare, and Icare PRO rebound tonometers; non-contact tonometer; and Tonopen XL in healthy elderly subjects.

Authors:  Yoshitake Kato; Shunsuke Nakakura; Naoko Matsuo; Kayo Yoshitomi; Marina Handa; Hitoshi Tabuchi; Yoshiaki Kiuchi
Journal:  Int Ophthalmol       Date:  2017-04-09       Impact factor: 2.031

2.  Comparison of ICare and IOPen vs Goldmann applanation tonometry according to international standards 8612 in glaucoma patients.

Authors:  Milena Pahlitzsch; Jeanette Brünner; Johannes Gonnermann; Anna-Karina B Maier; Necip Torun; Eckart Bertelmann; Matthias Kj Klamann
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

Review 3.  Tonometers-which one should I use?

Authors:  Kanza Aziz; David S Friedman
Journal:  Eye (Lond)       Date:  2018-02-19       Impact factor: 3.775

4.  Comparison of intraocular pressure as measured by three different non-contact tonometers and goldmann applanation tonometer for non-glaucomatous subjects.

Authors:  Seung Pil Bang; Chong Eun Lee; Yu Cheol Kim
Journal:  BMC Ophthalmol       Date:  2017-11-02       Impact factor: 2.209

5.  Comparison of rebound tonometry and non-contact airpuff tonometry to Goldmann applanation tonometry.

Authors:  Goktug Demirci; Sevil Karaman Erdur; Cafer Tanriverdi; Gokhan Gulkilik; Mustafa Ozsutçu
Journal:  Ther Adv Ophthalmol       Date:  2019-03-14

6.  Comparability of three intraocular pressure measurement: iCare pro rebound, non-contact and Goldmann applanation tonometry in different IOP group.

Authors:  Min Chen; Lina Zhang; Jia Xu; Xinyi Chen; Yuxiang Gu; Yuping Ren; Kaijun Wang
Journal:  BMC Ophthalmol       Date:  2019-11-14       Impact factor: 2.209

7.  Audit of outcomes following attendance at the City West drive-through IOP glaucoma clinic during the COVID-19 pandemic.

Authors:  Sarah Powell; Emer Doolan; Karen Curtin; Aoife Doyle; Colm O'Brien
Journal:  Ir J Med Sci       Date:  2022-01-16       Impact factor: 2.089

8.  Comparison of the iCare rebound tonometer and the Goldmann applanation tonometer.

Authors:  Feng Gao; Xu Liu; Qing Zhao; Yingzhe Pan
Journal:  Exp Ther Med       Date:  2017-02-24       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.